Subscription Preferences

Our response and support

How you can help

Resources and trusted information

Society news and updates

Undergraduates (BSc Pharmacology)

Undergraduates (Medical)

Postgraduates

Specialty Registrars

Jobs & opportunities

Events

Abstracts guidance & advice

Sponsor our meetings & events

Access support from the Society

Pharmacology Futures 2018 | 17 May 2018

About BPS education

Courses & workshops

Workshops

Prescribing

Teaching pharmacology

Outreach & schools

Blog

Pharmacology Matters Old

British Journal of Pharmacology

British Journal of Clinical Pharmacology

Pharmacology Research & Perspectives

Guide to PHARMACOLOGY

Society membership

Prizes, awards and grants

Bursaries

Visit our online Community

Further reading

Research Fortnight article written by David Phillips: 'Big pharma is broken, how can we fix it?'
Research Fortnight article written by David Fox from the Royal Society of Chemistry (RSC): 'Keep making the tablets'.
Research Fortnight article written by Mark Downs, chief executive of the Society of Biology, 'Drug discoverers must adapt to a more complex world'.
RSC News article, 'Removing boundaries: Enabling the movement of researchers across disciplines and the industry-academia interface'.
Comments from Mark Downs, chief executive of the Society of Biology, recently featured in the Nature article: 'AstraZeneca juggernaut heads for Cambridge' (£ - pay to view).

Share this page

About

Who we are
What we do
About pharmacology
Our public benefit
Partners & friends
Donations
Policy positions and statements
Our campaigns
- Animals in research
- Clinical pharmacology & the NHS
- Clinical Pharmacology Month (October)
- Drug Discovery Pathways Group
  - What does DDPG do?
  - Who is involved?
  - Skill statements
  - News & events
  - Further reading
- Focus on Pharmacology
- Learned Society Partnership on Antimicrobial Resistance
- Young pharmacologists